Kaiser Aluminum (NASDAQ:KALU) has everything I like to see in a company. I believe the company has opportunity to continue growing and perhaps experience multiple expansion. I like how much cash they return to shareholders. I like how little debt they have. They may not be the most
Elon Musk recently admitted that Tesla's stock value is out of control. "I do believe this market cap is higher than we have any right to deserve," he said in an interview for the Guardian newspaper in the UK about Tesla (NASDAQ:TSLA) shares.
Got a Yahoo account? Here’s what should be on your radar It’s official: Hearts can be hacked.
The FDA confirmed that St. Jude Medical’s implantable cardiac devices have vulnerabilities that could allow a hacker to access a device. Once in, they could deplete the battery or administer incorrect pacing or shocks, the FDA said on Monday.
Get your popcorn and settle in for a biotechnology Clash of the Titans. In one corner stands Celgene Corporation (NASDAQ:CELG), an oncology powerhouse on the rise. In the other corner stands Gilead Sciences, Inc. (NASDAQ:GILD), an antiviral heavyweight that may be past its prime.
Celgene’s star may be rising, but you’ll need to pay a steep premium for the stock. Gilead’s....More>>>
In this episode of Motley Fool Answers, Alison Southwick and Robert Brokamp are stepping back from their usual focus on investing, financial health, and retirement planning to think about a question that is equally important: What can you do to be happier?
After sorting through a raft of scientific studies on happiness, the team has found a handful of essential tips to share.
The big news over the weekend has been Facebook Inc.’s (NSDQ:FB) announcement to buy backstock worth $6B, starting in Q1 2017. This was a first in the history of the company. While it can come across as a surprise for a growing company to announce a share repurchase offering, the recent drop in FB stock price could have forced the management into action. The FB stock price is down by over....More>>>
The rise and fall of Fitbit Inc (NYSE:FIT) – the company and the stock – was largely in step with an incredible buzz stemming from the introduction of the company’s wares followed by the revelation that the wrist-worn devices don’t always take accurate pulse rates. The whole matter has raised one overarching question….what will it take for any company to get cardiac....More>>>
For the second day running, the Dow Jones Industrial Average attempted to rise to the 20,000 level, only to falter and back up some. With the market volume drying up fast as the Christmas holiday approaches, its looking more and more like the historical level may have to wait a little longer. The futures were trading slightly lower this morning, so we may open down again.
The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. Now that the U.S. presidential election is over and Hillary Clinton is somewhat out of the picture, major biotech companies can breathe a little easier knowing that....More>>>
This time I’ll take a look at the S&P 500 sectors. Ultimately, I will write two pieces covering the following two topics: The first section, which starts below, will deal with some basic quantitative stats and engineered features on the S&P 500 sectors. I will have a look at return stats, risk-reward tradeoffs, alternative measures of risk over return including details on the sectoral....More>>>
Related NE Benzinga's Top Downgrades JPMorgan Sees Opportunity In Oil Services, Says M&A Will 'Take Backseat' Noble Corp. – Complete Fleet Status As Of May 19, 2016 And Commentary (Seeking Alpha) Related FCX Benzinga's Top Initiations Freeport-McMoRan Shares Continue....More>>>
An unimpressive review of the Model X could be the latest in a series of unflattering events to take place for Tesla (NASDAQ:TSLA). For a company that survives so much on the narrative of its vision and the narrative of its products, a recent relatively unfavorable review by usual ally Consumer Reports could be spelling that more bad news is on the horizon for Tesla.
Yesterday, our Elite Opportunity Pronewsletter suggested large cap supermarket stock Kroger Co (NYSE: KR) as a potential speculative short trade:
I’m not going to dig deep into their financials, but trust me when I say we are not fans of Lululemon Athletica Inc. (LULU), The Kroger Co. (KR) and Nordstrom Inc. (JWN) right nowAs for KR and JWN, we just don’t think the current consumer....More>>>
Judging by some of the best-known retail stocks, youd think Americas shopping malls were ghost towns. Shares of Macys (M, $31.31) trade for 57% less than the price they commanded last July. Nordstrom (JWN, $36.68) has plunged by 55% since March 2015. And Kohls (KSS, $34.49) has sunk 56% since April 2015. Over the past year through June 14, SPDR S&P Retail ETF (XRT, $41.10), an exchange-traded....More>>>
U.S. equities were battered in the worst selloff since September 2016 as a series of developments have roiled President Trump over the past week — all related to former FBI director James Comey, Russia and former national security advisor Michael Flynn.
SAN FRANCISCO The massive ransomware attack that crippledmore than 20% ofhospitals in the United Kingdom anddisabled systemsin as many as 74 countriesappears to have been inadvertently stopped by a 22-year-old computer security researcher in England who began studying it Friday afternoon.
Lately, there have been a lot of questions about the overvaluation of stocks in the cybersecurity space. I've had contributors who think the entire sector should be shorted. I mean, regardless of growth rate, ROIC or P/E, just short the entire sector and its glory.
Fox News Network is being sued by a dozen black employees, some current and some former, who are charging the company with allowing years of racial discrimination and creating an abusive work environment.
And a thirteenth employee has filed a discrimination charge with the Equal Employment